PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.81%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
6.60%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
5.91%
Positive EBIT growth while TSM is negative. John Neff might see a substantial edge in operational management.
5.91%
Positive operating income growth while TSM is negative. John Neff might view this as a competitive edge in operations.
9.05%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
9.09%
EPS growth under 50% of TSM's 95.28%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
26.32%
Diluted EPS growth under 50% of TSM's 88.89%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
-9.46%
Reduced diluted shares while TSM is at 0.49%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-33.58%
Negative OCF growth while TSM is at 4.59%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-44.88%
Negative FCF growth while TSM is at 6.20%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
660.55%
10Y revenue/share CAGR above 1.5x TSM's 405.39%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
132.27%
5Y revenue/share CAGR above 1.5x TSM's 7.93%. David Dodd would look for consistent product or market expansions fueling outperformance.
103.68%
Positive 3Y CAGR while TSM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
3767.77%
OCF/share CAGR of 3767.77% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
83.91%
5Y OCF/share CAGR 1.25-1.5x TSM's 60.43%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
144.23%
3Y OCF/share CAGR above 1.5x TSM's 21.52%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1329.20%
Net income/share CAGR above 1.5x TSM's 225.03% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
356.93%
Positive 5Y CAGR while TSM is negative. John Neff might view this as a strong mid-term relative advantage.
413.54%
Positive short-term CAGR while TSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
1605.93%
10Y equity/share CAGR above 1.5x TSM's 337.10%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
154.20%
5Y equity/share CAGR above 1.5x TSM's 47.00%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
113.15%
3Y equity/share CAGR above 1.5x TSM's 12.44%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.65%
Our AR growth while TSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
17.11%
We show growth while TSM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.84%
Asset growth above 1.5x TSM's 2.16%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.65%
1.25-1.5x TSM's 4.77%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
9.08%
We increase R&D while TSM cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.49%
We expand SG&A while TSM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.